Hoppa till innehåll
Hoppa till innehåll

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 25 mars 2020. Database contains 231 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
201-152-2
78-87-5
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
203-444-5
106-93-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
Other legislation
07/08/2015
Details
431-890-2
166412-78-8
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
15/03/2016
Details
271-094-0
68515-51-5
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/01/2015
Details
629-719-3
1219010-04-4
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
696-364-9
133779-11-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
292-562-0
90640-43-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
-
-
Netherlands
Carcinogenic
Exposure
Mutagenic
STOT RE
Under development
Under development
No suggestion yet
13/04/2017
Details
230-528-9
7173-62-8
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
701-028-2
-
France
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Other
24/05/2019
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
11/09/2019
Details
-
-
Sweden
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
02/02/2017
Details
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
-
-
Austria
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
276-745-2
72629-94-8
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
03/05/2019
Details
212-485-8
822-06-0
Germany
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
235-921-9
13048-33-4
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
04/05/2015
Details
203-856-5
111-30-8
Sweden
Respiratory sensitiser
Skin sensitiser
Under development
Under development
No suggestion yet
08/07/2019
Details
231-781-8
7727-21-1
France
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other legislation
12/03/2020
Details
231-786-5
7727-54-0
France
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other legislation
09/03/2020
Details
232-565-6
9000-90-2
United Kingdom
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
12/09/2018
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
202-966-0
101-68-8
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
225-863-2
5124-30-1
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
220-239-6
2682-20-4
Denmark
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
04/05/2015
Details
203-080-7
103-11-7
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
204-881-4
128-37-0
France
Carcinogenic
Endocrine disruption
Exposure
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
17/01/2019
Details
219-799-4
2536-05-2
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
220-474-4
2778-42-9
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
256-032-2
42978-66-5
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
242-060-2
18172-67-3
Greece
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/07/2017
Details
-
-
Denmark
Respiratory sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
06/02/2015
Details
262-967-7
61788-32-7
Finland
Aggregated tonnage
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/09/2019
Details
206-801-3
375-95-1
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
-
-
Norway
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
17/01/2020
Details
247-421-8
26038-87-9
France
Endocrine disruption
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
D4
209-136-7
556-67-2
Germany
Aggregated tonnage
Bioaccumulation
Exposure
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/01/2018
Details
show/hide
Decanoic acid, nonadecafluoro-, sodium salt EC / List no: - | CAS no: 3830-45-3
Ammonium nonadecafluorodecanoate EC / List no: 221-470-5 | CAS no: 3108-42-7
Nonadecafluorodecanoic acid EC / List no: 206-400-3 | CAS no: 335-76-2
-
-
Sweden
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
30/01/2019
Details
206-400-3
335-76-2
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
25/01/2019
Details
206-803-4
376-06-7
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
200-579-1
64-18-6
Bulgaria
Bioaccumulation
Endocrine disruption
Other human toxicity
Persistence
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
258-649-2
53585-53-8
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Other
03/03/2020
Details
D5
208-764-9
541-02-6
United Kingdom
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/08/2015
Details
D5
208-764-9
541-02-6
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/01/2018
Details
400-370-7
6196-98-1
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Other
03/03/2020
Details
260-829-0
57583-35-4
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
05/07/2017
Details
603-051-2
125304-04-3
Germany
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
01/04/2015
Details
253-037-1
36437-37-3
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details

Export search results to:

Categories Display


Route: .live2